In vitro and ex vivo corneal penetration and absorption models

被引:76
作者
Agarwal, Priyanka [1 ]
Rupenthal, Ilva D. [1 ]
机构
[1] Univ Auckland, Buchanan Ocular Therapeut Unit, Dept Ophthalmol, New Zealand Natl Eye Ctr,Fac Med & Hlth Sci, Private Bag 92019, Auckland 1142, New Zealand
关键词
Ocular drug delivery; Corneal penetration; In vitro models; Ex vivo models; Diffusion cells; OCULAR DRUG-DELIVERY; EPITHELIAL-CELL LINE; EPSILON-CAPROLACTONE NANOSPHERES; LIQUID-CRYSTALLINE NANOPARTICLES; SOLID LIPID NANOPARTICLES; ISOLATED RABBIT CORNEA; CYCLOSPORINE-A; PIGMENTED RABBIT; OPHTHALMIC DRUGS; EYE DROPS;
D O I
10.1007/s13346-015-0275-6
中图分类号
TH7 [仪器、仪表];
学科分类号
080401 [精密仪器及机械];
摘要
Topical drug administration is the preferred route of drug delivery to the eye despite the poor bioavailability. To develop more efficient drug carriers, reliable in vitro or ex vivo models are required in the early stages of formulation development, with such methods being faster, cheaper, and more ethical alternatives to in vivo studies. In vitro cell culture models are increasingly being used for transcorneal penetration studies, with primary cell cultures and immortalized cell lines now giving way to the development of organotypic corneal constructs for studying ocular drug bioavailability. Artificially cultured human corneal equivalents are still in the early stages of development, but present tremendous potential for corneal penetration studies. Ex vivo models using excised animal tissue are also being used to study corneal penetration with promising results, although significant inter-species variations need to be considered. This review discusses the in vitro and ex vivo models currently being used to study corneal penetration and evaluates their advantages and limitations with a focus on diffusion cell assemblies. In addition to the tissue used, the diffusion cell set-up can significantly influence the penetration profile and should be cautiously adjusted to simulate clinical conditions.
引用
收藏
页码:634 / 647
页数:14
相关论文
共 126 条
[1]
Biodegradable Ocular Inserts for Sustained Delivery of Brimonidine Tartarate: Preparation and In Vitro/In Vivo Evaluation [J].
Aburahma, Mona Hassan ;
Mahmoud, Azza Ahmed .
AAPS PHARMSCITECH, 2011, 12 (04) :1335-1347
[2]
In Vitro corneal permeation of diclofenac from oil drops [J].
Ahuja, Munish ;
Sharma, Surendra Kumar ;
Majumdar, Dipak Kanti .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (10) :1739-1745
[3]
Viscous tetracaine hydrochloride 0.5% for topical anesthesia in cataract surgery [J].
Amiel, Howard .
EXPERT REVIEW OF OPHTHALMOLOGY, 2008, 3 (01) :17-20
[4]
[Anonymous], INT J PHARM PHARM SC
[5]
[Anonymous], TECHN BRIEF
[6]
[Anonymous], 2011, INVEST OPHTHALMOL VI, DOI DOI 10.1021/mp500401t
[7]
[Anonymous], [No title captured]
[8]
[Anonymous], IN VITRO CORNEAL MOD
[9]
[Anonymous], [No title captured]
[10]
[Anonymous], T2086 AAPS